Technical Analysis for KLTO - Klotho Neurosciences, Inc.

Grade Last Price % Change Price Change
F 0.42 -14.47% -0.07
KLTO closed down 14.47 percent on Friday, November 1, 2024, on 32 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -14.47%
Wide Bands Range Expansion -14.47%
Down 3 Days in a Row Weakness -14.47%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 22 hours ago
60 Minute Opening Range Breakdown about 23 hours ago
Down 5% 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Klotho Neurosciences, Inc. Description

Klotho Neurosciences, Inc. formerly ANEW MEDICAL, INC., is a Nasdaq-listed pharmaceutical company with the ticker symbol KLTO. The company specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders. The Company obtained exclusive worldwide rights to platform technologies and knowhow to develop cutting edge protein, gene and cell therapies to treat age-related pathologies such as ALS, Alzheimer’s and Parkinson’s disease, multiple sclerosis, and rare neurodegenerative diseases. The company is managed by a team of individuals and advisors that are highly experienced in medical product development and commercialization of medical products.


Classification

Sector: Financial Services
Industry: Shell Companies
Keywords: Pharmaceutical Multiple Sclerosis Platform Technologies Parkinson’s Disease

Is KLTO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.1
52 Week Low 0.3901
Average Volume 607,854
200-Day Moving Average 5.33
50-Day Moving Average 0.72
20-Day Moving Average 0.55
10-Day Moving Average 0.55
Average True Range 0.10
RSI (14) 35.06
ADX 18.74
+DI 17.88
-DI 25.08
Chandelier Exit (Long, 3 ATRs) 0.57
Chandelier Exit (Short, 3 ATRs) 0.70
Upper Bollinger Bands 0.71
Lower Bollinger Band 0.38
Percent B (%b) 0.11
BandWidth 60.26
MACD Line -0.07
MACD Signal Line -0.07
MACD Histogram 0.0
Fundamentals Value
Market Cap 3.69 Million
Num Shares 8.8 Million
EPS -1.27
Price-to-Earnings (P/E) Ratio -0.33
Price-to-Sales 0.00
Price-to-Book 1.87
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.60
Resistance 3 (R3) 0.61 0.56 0.57
Resistance 2 (R2) 0.56 0.51 0.55 0.56
Resistance 1 (R1) 0.49 0.49 0.46 0.48 0.55
Pivot Point 0.44 0.44 0.43 0.43 0.44
Support 1 (S1) 0.37 0.39 0.34 0.36 0.29
Support 2 (S2) 0.32 0.37 0.31 0.28
Support 3 (S3) 0.25 0.32 0.27
Support 4 (S4) 0.24